Similarly, HSP90 inhibitors substantially reduced phosphorylated-KIT and total KIT expression with decreased cell survival observed in KIT-positive GIST (Bauer et al, 2006). This evidence concerns the gene HSP90AA1 and gastrointestinal stromal tumor.